Regional Centre for Biotechnology (RCB), Faridabad, Haryana-121001, has invited applications for admission to the MS-PhD ...

From Phil King’s Regal Partners to Russel Pillemer’s Pengana Capital, fund managers loved vision treatment hopeful Opthea.

Alcon has acquired a majority interest in Aurion Biotech, according to a press release. Aurion will operate as a separate ...

Graduates are prepared for positions in research, and industrial research and development laboratories, sales/technical representation in biotechnology, chemical or pharmaceutical companies, or to ...

Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in individuals who are blind or losing vision ...

People often believe pursuing a degree from reputed universities and colleges can make them better candidates in the job ...

A Cambridge PhD, Marika Niihori, faced a tough job market, receiving over 70 rejections. Despite her prestigious degree, she ...

Aurion is developing AURN001, a clinical-stage allogeneic cell therapy asset, for corneal edema secondary to corneal ...

New non-clinical data strengthens evidence of contributions of IO102 and IO103 to tumor growth control through target specific T-cell ...

AM CT on Friday, March 28, 2025PRINCETON, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company ...

Marika Niihori, who completed her PhD in October last year, initially believed that securing a high-paying job would be easy.